PRF1 and neoplasm: Concomitant TCE binding to both targets facilitates trafficking of T-cells into the tumor microenvironment and is sufficient to trigger T-cell activation and lysis of the tumor cells resulting from the release of pro-apoptotic perforins and granzymes while activating other immune cells through pro-inflammatory cytokines [9].